Novo Nordisk, Chip Ganassi Racing Teams and Charlie Kimball Honor the Diabetes Community With the No. 42 Tresiba® (insulin degludec injection 200 Units/mL) Chevrolet at the 100th Running of the Indianapolis 500
Basal Insulin Tresiba Approved for Teens and Kids as Young as One
Novo seeks to strengthen Tresiba label in US - PMLiVE
Tresiba «Novo Nordisk» - Felleskatalogen
New economic data finds Novo Nordisk's insulin degludec most cost effective diabetic treatment
Novo Nordisk launches Tresiba (insulin degludec) in United Kingdom and Denmark
Novo Nordisk once-weekly insulin icodec beats Tresiba, matches Sanofi's Lantus in trials | Seeking Alpha
Novo Nordisk releases Tresiba long-acting insulin - CDR – Chain Drug Review
Tresiba (Insulin Degludec) | Aark Pharmaceuticals
Novo Nordisk to launch insulin injection Tresiba in India - The Economic Times
Nonprofit drugmaker will soon sell insulin for $30 a vial, regardless of insurance | WPMI